Overview
AGY Therapeutics' relentless dedication to innovation in advancing treatments for Central Nervous System (CNS) disorders sets them apart as a pioneering force in the pharmaceutical industry. Through cutting-edge research and development, AGY Therapeutics consistently pushes the boundaries of what is possible in treating conditions that impact the CNS. Their innovative approaches encompass a wide range of neurological disorders, from Alzheimer's disease to Parkinson's, with a keen focus on improving quality of life for patients.
Actions
Primary Address
270 E. Grand Avenue, San Francisco, CA, United States 94080
Social Media